Sapphiros and binx health Combine to Form Onvaro, a Next-Generation Diagnostics Company
Business Wire•04/11/2026•07:00 ET
0
Key Highlights
- ➤Sapphiros and binx health combine to form diagnostics company Onvaro
- ➤KKR, Hildred, and EQT Life Sciences commit new capital to Onvaro
- ➤binx io platform has more than 1,000 installed instruments and national distribution
- ➤Mike Karsonovich becomes Onvaro CEO; Namal Nawana named Lead Director
- ➤Onvaro pipeline spans respiratory, women’s health, infectious disease, and blood collection
Expert Statements
Ali Satvat, Global Head of Health Care Strategic Growth at KKR
“Together, these businesses create a more compelling opportunity than either could deliver alone: a platform with the commercial traction, technology, and manufacturing depth to become an important player in the shift toward decentralized diagnostics.”
Andrew Goldman, Co-Founder and Managing Partner at Hildred
“Combining binx health with Sapphiros to form Onvaro gives the business the breadth, scale, and capabilities needed to capture new opportunities.”
Christoph Broja, Partner at EQT Life Sciences
“The combination of Sapphiros and binx health brings together complementary technologies, commercial capabilities, and deep expertise to address this opportunity at scale.”
Mike Karsonovich, Chief Executive Officer of Onvaro
“Our opportunity now is to bring these strengths together and build a platform that reaches patients wherever testing happens — making high-quality diagnostics faster, more accessible, and more connected to care.”
Namal Nawana, Lead Director of Onvaro and Founder of Sapphiros
“We’re excited to accelerate progress with Onvaro and scale a first-of-its-kind connected diagnostics platform that turns test results into care.”
Sapphiros and binx health Combine to Form Onvaro, a Next-Generation Diagnostics Company
Combination unites two innovative diagnostics platforms to build a first-of-its-kind connected point-of-need diagnostics platform
Get started
Create a free account to read the full story.